Robotics Town Hall
Monday, May 6, 2013
1 – 3 p.m.
San Diego Convention Center, Room 6A
2013 Robotics Town Hall Meeting Schedule
|Welcome and Introduction
1 – 1:05 p.m.
Ralph V. Clayman, MD
School of Medicine, UC Irvine
"The advent of robotic surgery was clearly outlined by Kurt Semm, the father of modern day laparoscopy, in 1999. As a true pioneer, he applauded the progress that would eventually eclipse his own contribution. Today, 14 years later, robotic surgery has permeated all areas of surgery regardless of specialty. In the ensuing town hall, we will be treated to sage views of experts and leaders in the field with regard to the rationale, comparative effectiveness, economic impact, and future of robotic surgery on earth and possibly beyond."
Dr. Ralph V. Clayman is a graduate of Grinnell College and the University of California – San Diego, School of Medicine. Following his residency in Urology at the University of Minnesota and an AUA research scholarship at the University of Texas – Southwestern, he spent 17 years at Washington University in St. Louis; attaining the rank of Professor of Urology and Radiology. In 1990, he and his surgical team performed the world's first laparoscopic removal of a kidney.
In January 2002, he accepted the Chair of the newly formed Department of Urology at the University of California – Irvine; within 5 years, the program was rated among the top 20 in the country by U.S. News and World Report. He is a co-founder of the Endourology Society and has served as its President; he continues to serve as co-editor of the Journal of Endourology. In 1984, he initiated the first fellowship experience in endourology; among the 30 graduating fellows, 19 entered academic urology among whom four are currently departmental chairs. He holds 13 patents on devices/instruments used in minimally invasive surgery and has published over 400 manuscripts. In 2010, he accepted the role of Dean of the School of Medicine at UC Irvine.
1:05 – 1:17 p.m.
Frederic Moll, MD
Co-Founder of Intuitive Surgical
"Robots now play a significant role in the delivery of surgical therapy. What are the clinical advantages to robotic technique and how has the clinical value equation evolved in the last decade?"
Dr. Moll is the founder and CEO of Hansen Medical. Dr. Moll founded Hansen in 2002, bringing with him more than 20 years of medical device and high technology experience. In 1995, Dr. Moll founded Intuitive Surgical, the world leader in surgical robotics, and served as the company's first CEO. Prior to Intuitive Surgical, Dr. Moll co-founded Origin Medsystems, Inc. Dr. Moll served as medical director of Guidant's surgical device division from 1992 – 1995. Before co-founding Origin Medsystems, Dr. Moll invented the safety trocar, which fostered in modern general laparoscopic surgery and he founded Endotherapeutics. Dr. Moll holds a B.A. degree in economics from the University of California at Berkeley, a M.S. degree in management from Stanford University, and a M.D. from the University of Washington. He is a distinguished speaker and lecturer, and is the author of numerous scientific articles. He currently serves on the boards of several Silicon Valley healthcare companies.
|Comparative Effectiveness of Robotic Surgery – Has it Lived Up to the Hype?
1:17 – 1:29 p.m.
Sheldon Greenfield, MD
Health Policy Research Institute, UC Irvine
Greenfield is a recipient of the Glaser Award of the Society of General Internal Medicine and the 1999 Novartis Global Outcomes Leadership Award. Dr Greenfield was elected to the IOM in 1996. He is current chair of the National Quality Forum Advisory Panel for Diabetes and Chronic Kidney Disease, and a member of the NQF Outcomes Steering Committee. He was recently appointed to the California Medi-Cal Performance Advisory Committee, which oversees the state's $46 billion Medicaid program. He practices general internal medicine one day a week at the Gottschalk Clinic on the campus of UC Irvine.
|Robotic Urologic Surgery: Is It Affordable – Loss Leader or Cash Cow?
1:29 – 1:49 p.m.
Chief Financial Officer
University of California, Irvine Medical Center
Frieling oversees accounting and financial reporting, patient financial services, revenue cycle management, decision support, budget, capital planning and financing, clinical enterprise managed care contracting, health information management, case management and the transfer center. He also offers strategic financial advice to UC Irvine School of Medicine, the medical center's educational arm.
Frieling is a proactive leader and visionary who creates and implements financial plans to achieve the organization's overall vision, mission, goals and objectives. His expertise guides key business decisions in support of the organization's long-term strategic plan. Frieling has developed complex, multiple-year financial plans that have resulted in University of California systemwide approval for $393 million toward the construction of the state-of-the-art UC Irvine Douglas Hospital, which opened its doors in 2009, and $242 million for five additional construction initiatives. He also provides invaluable recommendations to improve operational performance and optimize the medical center's revenue streams.
Frieling has more than 26 years of experience in leading the operations and finance functions of large academic health centers. He previously worked at University of Colorado Health Sciences Center in Denver, where he oversaw the operational and financial management of clinical and support departments. Frieling holds a Master of Health Administration with an emphasis in finance from the University of Colorado Graduate School of Business in Denver, and a bachelor degree in biology from Carroll College in Helena, Mont. He maintains an active membership with the Healthcare Financial Management Association.
|The Curiosity Mars Rover: Robotic Scientist, Explorer, and Potential Ancestor to the Future of Urologic Surgery
1:49 – 2:01 p.m.
Engineering Development and Operations Manager
Mars Science Laboratory, NASA
"Where were you when Curiosity landed? Did you stop to think about how this intrepid explorer could serve as inspiration for the future of robotic surgery? This talk explores the advances in interplanetary robotic technology that have turned science fiction into the exciting Mars Science Laboratory mission at Gale Crater. Could a future version of the Curiosity Rover be an integral part of urologic surgery? Let's dream together!"
Jordan Evans is the Engineering Development and Operations Manager for the Mars Science Laboratory (MSL) "Curiosity" rover project at NASA's Jet Propulsion Laboratory. Since 2006, Mr. Evans has led the MSL team through the challenges of Curiosity's design, development, testing and operations on the surface of Mars. His past projects and experience encompass a wide array of aerospace topics including the B-2 Stealth Bomber, Hubble Space Telescope, and a space-based Gravitational Wave Detector. Publications from Mr. Evans include papers on bonded joints, compensation for "self-gravity," systems engineering challenges, managing critical tests, and cleaning of instruments for detection of organics on Mars.
Regularly called on to lead the investigation of mission-impacting problems, Mr. Evans brings a healthy mix of technical experience, leadership skills, and humor to otherwise uncomfortable situations and has received numerous awards for his leadership and ability to balance risk effectively. As a "rocket scientist," Mr. Evans, is a consultant for the National Academy of Sciences' "Science & Entertainment Exchange" and serves as a science consultant for major motion pictures.
An accomplished jazz musician, Mr. Evans regularly performs with big bands and small jazz ensembles in the Southern California area. He is married with two children and resides in La Crescenta, California.
|Questions from the Audience
2:01 – 2:45 p.m.
Moderator: Inderbir S. Gill, MD, MCh
Chairman & Professor
Department of Urology
University of Southern California
Dr. Gill's primary focus is advanced robotic urologic oncologic surgery, with one of the world's largest aggregate laparoscopic/robotic experiences in approx 7,500 cases in the United States. An acknowledged world leader in robotic/laparoscopic partial nephrectomy for renal cancer, he and his team have performed this procedure in over 2,000 patients, the world's largest series. His team's many scientific innovations in robotic & laparoscopic oncologic surgery have generated world-leading clinical series of radical cystectomy with intra-corporeal urinary diversion (n=150+), radical prostatectomy (n= 5,000+) and renal cryoablation. His team is actively developing flexible robotics, natural orifice and single-port laparoscopic surgery in urology, innovative concepts towards scar-free surgery. Over the past 3 years, Dr Gill and his team are focusing on developing novel image-guided targeted biopsy and lesion-specific focal therapy treatments for prostate cancer.
|Moderator: Peter T. Scardino, MD
Chairman, Department of Surgery
Memorial Sloan-Kettering Cancer Center
Dr. Scardino is the author of more than 300 publications on prostate cancer and he served as an editor for four editions of the Comprehensive Textbook of Genitourinary Oncology. He was the founding Editor-in-Chief of Nature Reviews Urology, and he is Associate Editor of the Annual Review of Medicine. Dr. Scardino has served as Chair of the NCCN Guidelines Committee on the Treatment of Prostate Cancer and as Co-chair of the National Cancer Institute Progress Review Group on Prostate Cancer.
|What is the Future of the Surgeon? Handiwork or Assembly Line?
2:45 – 3 p.m.
Richard Satava, MD, FACS
Professor of Surgery
University of Washington Medical Center
Senior Science Advisor at the US Army Medical Research and Materiel Command
"What is the Future of the Surgeon? Handiwork or Assembly Line? Clearly the Surgeon of the Future will NOT perform 'assembly line' surgery, however two changes are already beginning to emerge: 1) The surgeon will plan and rehearse an operation on patient specific CT data ("editing" out errors like a word processor), save and send the final surgical procedure to a robotic system to perform the operation many times faster, more precise and without error under surgeon supervision and 2) Many, if not most, of the surgical instruments will be intelligent, directed-energy systems rather than mechanical instruments, allowing the surgeon to perform procedures not only non-invasively but also at the cellular and molecular level."
Dr. Satava is Professor of Surgery at the University of Washington Medical Center, and Senior Science Advisor at the US Army Medical Research and Materiel Command in Ft. Detrick, MD. Prior positions include Professor of Surgery at Yale University and a military appointment as Professor of Surgery in the Army Medical Corps assigned to General Surgery at Walter Reed Army Medical Center and Program Manager of Advanced Biomedical Technology at the Defense Advanced Research Projects Agency.
During his 23 years of military surgery he has been an active flight surgeon, an Army astronaut candidate, MASH surgeon for the Grenada Invasion, and a hospital commander during Desert Storm, all the while continuing clinical surgical practice. While striving to practice the complete discipline of surgery, he is aggressively pursuing the leading edge of advanced technologies to formulate the architecture for the next generation of Medicine.
Dr. Satava completed his undergraduate training at Johns Hopkins University and attended medical school at Hahnemann University of Philadelphia.